about
Coenzyme Q10 for heart failureCoenzyme Q10 for heart failurePreparation and characterization of novel coenzyme Q10 nanoparticles engineered from microemulsion precursorsEstrogen, mitochondria, and growth of cancer and non-cancer cellsMitochondrial dysfunction in obesity: potential benefit and mechanism of Co-enzyme Q10 supplementation in metabolic syndromeCoenzyme q10 therapyComplementary and alternative medicine in cardiovascular disease: what is the evidence it works?Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics.New self-nanoemulsifying drug delivery system (SNEDDS) with amphiphilic diblock copolymer methoxy poly (ethylene glycol)-block-poly (ε-caprolactone).Fermented wheat germ extract (avemar) in the treatment of cardiac remodeling and metabolic symptoms in rats.Overview on coenzyme Q10 as adjunctive therapy in chronic heart failure. Rationale, design and end-points of "Q-symbio"--a multinational trial.Can coenzyme Q10 improve vascular function and blood pressure? Potential for effective therapeutic reduction in vascular oxidative stress.Coenzyme Q10 and diabetic endotheliopathy: oxidative stress and the 'recoupling hypothesis'.Antioxidant supplements: Effects on disease and aging in the United States population.Effects of acute and 14-day coenzyme Q10 supplementation on exercise performance in both trained and untrained individualsSolanesyl diphosphate synthase, an enzyme of the ubiquinone synthetic pathway, is required throughout the life cycle of Trypanosoma brucei.Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS).Ischemic heart disease and antioxidants: mechanistic aspects of oxidative injury and its prevention.Effects of glucose/insulin perturbations on aging and chronic disorders of aging: the evidence.A randomized, double-blind, crossover study on the pharmacokinetics of a novel formulation of CoQ₁₀ with pyridoxal 5'-phosphate and phosphatidyl choline.Effects of combined quercetin and coenzyme Q(10) treatment on oxidative stress in normal and diabetic rats.Protective effect of coenzyme Q10-loaded liposomes on the myocardium in rabbits with an acute experimental myocardial infarction.Cardioprotection by farnesol: role of the mevalonate pathway.Heart failure and statins--why do we need a clinical trial?The effect of coenzyme Q10 on the pharmacokinetic parameters of theophylline.Electrocardiographic and hemodynamic effects of coenzyme Q10 in healthy individuals: a double-blind, randomized controlled trial.Coenzyme Q10 Supplementation Prevents Iron Overload While Improving Glycaemic Control and Antioxidant Protection in Insulin-Resistant Psammomys obesus.Qualitative electron microscopic analysis of cultured chick embryonic cardiac and skeletal muscle cells: the cellular effect of coenzyme q10 after exposure to triton x-100.Coenzyme Q10 protect against ischemia/reperfusion induced biochemical and functional changes in rabbit urinary bladder.Circadian and seasonal variation of endogenous ubiquinone plasma level.Development of self-microemulsifying drug delivery system for oral delivery of poorly water-soluble nutraceuticals.Evaluation of the mutagenic and genotoxic potential of ubiquinol.Encapsulation efficiency of coenzyme Q10‐liposomes in alginate
P2860
Q24194154-620C2E0D-EF1D-43BA-B7F3-8C997FDFEE89Q24235690-0E671918-D4CE-4AA0-B993-3FCCAF241CFFQ24648098-E5B3597B-0BA6-417A-B6D9-5439A605D25DQ24799692-23CBC8F8-0CCF-49DC-B5F0-34C17683E55BQ27009336-7C8C4E59-95E1-4D2A-B5F3-558B24D30C82Q33956936-DBAC003F-4200-4549-BBB2-B73E31DA17B6Q34191329-C224F8B4-6A05-4554-AC0C-2E18A350F4D1Q34503981-55719F49-F46E-49E4-8B49-34A83C31026AQ34616076-97B547A4-D435-4885-83D1-6FB771E1591EQ35103679-93CB3E6D-3CC4-4136-A279-2D0535B04AC3Q35616463-CCC37AB6-2A82-4035-AC28-F7382686B728Q35616474-E6958ACB-C863-4417-B989-35D2A9FBB30FQ35837905-5AF074AE-D215-4B4D-AD05-9588092164D1Q36270104-01CEF8C6-438A-40C1-87C3-C75C1E8FC7D6Q36562833-E8C0F7A5-2CD2-4036-94D3-DF2B8D6443B7Q37545171-0D284DE9-D3C7-4BF9-8DFE-586367D4E6DAQ37988960-89BEC1DC-4387-49DC-B1B1-6F9DD5C43B1FQ40524422-57DA9110-63FB-427A-BC70-81E7A87B2CFCQ41606449-91523127-E98C-476B-A55E-3804FD20EE0FQ42720363-67A540BA-9E97-46ED-A217-DBFDC39E2107Q44145979-85DD62C7-DCD3-4BF2-833F-955210032C26Q45305777-F4BCF147-CC66-4C27-9010-64A66FB71D6AQ45722496-5E3AB138-21CF-4AEB-8A75-F7391FC5A79DQ46415573-2F9EE230-B583-4D2B-9D3A-00F19471CEA3Q46428594-8C580C72-08C8-48AB-B104-6C45DE2BAF58Q46438608-5F44604A-7710-4520-9D9C-93E3B47379B7Q46717636-5FDF8C61-E83D-4768-8297-B1FBBAF785C1Q46801990-26C5BBAA-B0DD-4BFE-880E-82D95C8BA5C0Q46828035-B2C3D314-083B-41C2-9E85-0DFB609497D4Q46977096-4F49BD9A-95D3-458C-AA74-A72FB3B7AA28Q47749909-EF16588A-2979-41AB-82FB-B554F13E57B4Q50066005-3AF96C08-0B79-4679-B142-2E35008F880EQ57378900-87B25E61-CF25-443E-AE56-8C448DFA2633
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Co-enzyme Q10: a new drug for cardiovascular disease.
@en
Co-enzyme Q10: a new drug for cardiovascular disease.
@nl
type
label
Co-enzyme Q10: a new drug for cardiovascular disease.
@en
Co-enzyme Q10: a new drug for cardiovascular disease.
@nl
prefLabel
Co-enzyme Q10: a new drug for cardiovascular disease.
@en
Co-enzyme Q10: a new drug for cardiovascular disease.
@nl
P2860
P1476
Co-enzyme Q10: a new drug for cardiovascular disease.
@en
P2093
Frishman WH
Greenberg S
P2860
P304
P356
10.1002/J.1552-4604.1990.TB01862.X
P577
1990-07-01T00:00:00Z